Product Images Pramipexole Dihydrochloride

Pramipexole Dihydrochloride Extended-Release Tablets at 0.375 mg strength. No additional information available.*

This is a prescription drug called Pramipexole in the form of Extended-Release Tablets. The recommended dosage is not mentioned, but it is clear that the tablets should be swallowed whole and not chewed, crushed, or divided. Each extended-release tablet contains 0.375 mg Pramipexole dihydrochloride. The drug should be stored between 20° to 25°C (68" to 77°F) and must be protected from exposure to high humidity, and kept out of reach of children. This drug is manufactured by Macleods Pharmaceuticals Ltd in India and distributed by Macleods Pharma USA Inc.*

This is a description of a medication called Pramipexole, manufactured by Macleods Pharma USA, Inc. It comes in the form of extended-release tablets and is used to treat symptoms of Parkinson's disease. The dosage is 0.75 mg and it should be swallowed whole and not chewed, crushed or divided. The tablets should be stored at 20° to 25°C and protected from exposure to high humidity. The medication is only available through prescription and comes with additional accompanying prescribing information.*

This is a medication for Pramipexole Dihydrochloride Extended-Release tablets, with a concentration of 1.5mg per tablet. It is only available in the original container and must be swallowed whole. The recommended storage temperature is between 20°C and 25°C, and it should not be exposed to high humidity. It is manufactured by Macleods Pharma USA, Inc., under the supervision of the USP Control Room Temperature guidelines. There is a warning to keep the medication out of children's reach.*

The text is a mixture of alphanumeric characters and does not form a coherent description, thus it is not available.*

This text is a prescribing information for dihydrochloride extended-release tablets of Pramipexole. The tablets should not be chewed, crushed, or divided, and should be stored between 20°C to 25°C. Each extended-release tablet contains 2.25 mg pramipexole dihydrochloride. The label specifies the unit of use container and the manufacturer of the drug. The text also contains some product details such as the NDC code of the drug, dosage, and storage information.*

Pharme NDC 3334221307 is a medication that comes in a container with 30 extended-release tablets. Each tablet contains 3.75 mg of pramipexole dihydrochloride monohydrate, which should not be chewed, crushed or divided. The tablets must be swallowed whole. The medication should be stored in a controlled room temperature, and protected from high humidity, and children. The manufacturer is Macleods Pharma USA, Inc., located in Plainsboro, NJ.*

This is a prescription drug with the NDC code 33342.21207 containing 3mg of Pramipexole dihydrochloride, USP. It is an extended-release tablet that is swallowed whole and should not be chewed, crushed or divided. The tablets should be stored at a temperature range of 20°C to 25°C with excursions permitted to 15°C to 30°C. This drug should be dispensed only in the original USP controlled room temperature unit of use container. Macleods Pharma USA, Inc. is the manufacturer and it is manufactured by Macleods Pharmaceuticals Lid.*

This is a prescription drug with the NDC code 3334221407. It contains 4.5mg Pramipexole Dihydrochloride equivalent to 4.23mg Pramipexole. The tablets must be swallowed whole and should not be chewed, crushed, or divided. They must be stored within the temperature range of 20°C to 25°C (68°F to 77°F) and protected from exposure to high humidity. The medication is manufactured by Macleods Pharma USA, Inc. and distributed in a unit of use container with 30 tablets.*